Fluorescent-based methods for gene knockdown and functional cardiac imaging in Zebrafish

Molecular Biotechnology

Volumn 55, Issue 2, 2013, Pages 131-142

  Umemoto, Noriko ^a   Nishimura, Yuhei ^a,b,c   Shimada, Yasuhito ^a,b,c   Yamanaka, Yukiko ^a   Kishi, Seiya ^a   Ito, Saki ^a   Okamori, Kana ^a   Nakamura, Yuuki ^a   Kuroyanagi, Junya ^a   Zhang, Zi ^a   Zang, Liqing ^a   Wang, Zhipeng ^a   Nishimura, Norihiro ^a   Tanaka, Toshio ^a,b,c  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c MIE UNIVERSITY   (Japan)

Author keywords

Bodipy ceramide; Cardiac function; Cardiac troponin T; Cardiomyopathy; Gene dosage effect; Gene knockdown; Human disease model; Lissamine; Morpholino; Zebrafish

Indexed keywords

BODIPY-CERAMIDE; CARDIAC FUNCTIONS; CARDIAC TROPONIN; CARDIOMYOPATHY; GENE DOSAGE; GENE KNOCK DOWN; HUMAN DISEASE MODELS; LISSAMINE; MORPHOLINO; ZEBRAFISH;

CERAMIDES; FLUORESCENCE; GENES; PROTEINS;

HEART;

ARTICLE; CARDIAC IMAGING; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; GENE SILENCING; HEART FUNCTION; IMAGE ANALYSIS; NONHUMAN; ZEBRA FISH;

ANIMALIA; DANIO RERIO;

ANIMALS; CARDIAC IMAGING TECHNIQUES; EMBRYO, NONMAMMALIAN; FLUORESCENT DYES; GENE KNOCKDOWN TECHNIQUES; HEART; HEART RATE; HUMANS; MODELS, ANIMAL; MORPHOLINOS; MUTATION; MYOCARDIAL CONTRACTION; OLIGONUCLEOTIDES, ANTISENSE; PHENOTYPE; TROPONIN T; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84888201660     PISSN: 10736085     EISSN: 15590305     Source Type: Journal    
DOI: 10.1007/s12033-013-9664-6     Document Type: Article

References (39)

1. Kleinhammer, A.; Deussing, J.; Wurst, W.; Kühn, R. (2011). Conditional RNAi in mice. Methods, 53(2), 142-150.
2. Delic, S.; Streif, S.; Deussing, J. M.; Weber, P.; Ueffing, M.; Hölter, S. M.; et al. (2008). Genetic mouse models for behavioral analysis through transgenic RNAi technology. Genes, Brain, and Behavior, 7(7), 821-830.
3. Knollmann, B. C.; Potter, J. D. (2001). Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy. Trends in Cardiovascular Medicine, 11(5), 206-212.
4. Nishii, K.; Morimoto, S.; Minakami, R.; Miyano, Y.; Hashizume, K.; Ohta, M.; et al. (2008). Targeted disruption of the cardiac troponin T gene causes sarcomere disassembly and defects in heartbeat within the early mouse embryo. Developmental Biology, 322(1), 65-73.
5. Ahmad, F.; Banerjee, S.; Lage, M.; Huang, X.; Smith, S.; Saba, S.; et al. (2008). The role of cardiac troponin T quantity and function in cardiac development and dilated cardiomyopathy. PLoS ONE, 3(7), e2642.
6. Lee, S. K.; Kumar, P. (2009). Conditional RNAi: towards a silent gene therapy. Advanced Drug Delivery Reviews, 61(7-8), 650-664.
7. Tu, S.; Chi, N. C. (2012). Zebrafish models in cardiac development and congenital heart birth defects. Differentiation, 84(1), 4-16.
8. Oka, T.; Nishimura, Y.; Zang, L.; Hirano, M.; Shimada, Y.; Wang, Z.; et al. (2010). Diet-induced obesity in zebrafish shares common pathophysiological pathways with mammalian obesity. BMC Physiology, 10, 21.
9. Watanabe, K.; Nishimura, Y.; Oka, T.; Nomoto, T.; Kon, T.; Shintou, T.; et al. (2010). In vivo imaging of zebrafish retinal cells using fluorescent coumarin derivatives. BMC Neuroscience, 11, 116.
10. Tainaka, T.; Shimada, Y.; Kuroyanagi, J.; Zang, L.; Oka, T.; Nishimura, Y.; et al. (2011). Transcriptome analysis of anti-fatty liver action by Campari tomato using a zebrafish diet-induced obesity model. Nutrition and Metabolism, 8, 88.
11. Nasevicius, A.; Ekker, S. (2000). Effective targeted gene 'knockdown' in zebrafish. Nature Genetics, 26(2), 216-220.
12. Tanaka, T.; Oka, T.; Shimada, Y.; Umemoto, N.; Kuroyanagi, J.; Sakamoto, C.; et al. (2008). Pharmacogenomics of cardiovascular pharmacology: Pharmacogenomic network of cardiovascular disease models. J Pharmacol Sci, 107(1), 8-14.
13. Wang, Z.; Nishimura, Y.; Shimada, Y.; Umemoto, N.; Hirano, M.; Zang, L.; et al. (2009). Zebrafish beta-adrenergic receptor mRNA expression and control of pigmentation. Gene, 446, 18-27.
14. Eisen, J.; Smith, J. (2008). Controlling morpholino experiments: Don't stop making antisense. Development, 135(10), 1735-1743.
15. Kamachi, Y.; Okuda, Y.; Kondoh, H. (2008). Quantitative assessment of the knockdown efficiency of morpholino antisense oligonucleotides in zebrafish embryos using a luciferase assay. Genesis, 46(1), 1-7.
16. Huang, W.; Zhang, R.; Xu, X. (2009). Myofibrillogenesis in the developing zebrafish heart: A functional study of tnnt2. Developmental Biology, 331(2), 237-249.
17. Sehnert, A. J.; Huq, A.; Weinstein, B. M.; Walker, C.; Fishman, M.; Stainier, D. Y. (2002). Cardiac troponin T is essential in sarcomere assembly and cardiac contractility. Nature Genetics, 31(1), 106-110.
18. Cooper, M.; D'Amico, L.; Henry, C. (1999). Confocal microscopic analysis of morphogenetic movements. Methods in Cell Biology, 59, 179-204.
19. Westerfield, M. (2007). The zebrafish book: A guide for the laboratory use of zebrafish (Danio rerio). Eugene: University of Oregon Press.
20. Lister, J.; Robertson, C.; Lepage, T.; Johnson, S.; Raible, D. (1999). nacre encodes a zebrafish microphthalmia-related protein that regulates neural-crest-derived pigment cell fate. Development, 126(17), 3757-3767.
21. Collins, T. (2007). ImageJ for microscopy. BioTechniques, 43(1 Suppl), 25-30.
22. Jacob, E.; Drexel, M.; Schwerte, T.; Pelster, B. (2002). Influence of hypoxia and of hypoxemia on the development of cardiac activity in zebrafish larvae. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, 283(4), R911-R917.
23. Nakae, I.; Matsuo, S.; Tsutamoto, T.; Matsumoto, T.; Mitsunami, K.; Horie, M. (2007). Assessment of cardiac function in patients with heart disease by quantitative gated myocardial perfusion SPECT. Annals of Nuclear Medicine, 21(6), 315-323.
24. Gentleman R IR: The R Project for Statistical Computing. R Development Core Team. http://www.R-project.org.
25. Hsiao, C.; Tsai, W.; Horng, L.; Tsai, H. (2003). Molecular structure and developmental expression of three muscle-type troponin T genes in zebrafish. Developmental Dynamics, 227(2), 266-279.
26. Hove, J.; Köster, R.; Forouhar, A.; Acevedo-Bolton, G.; Fraser, S.; Gharib, M. (2003). Intracardiac fluid forces are an essential epigenetic factor for embryonic cardiogenesis. Nature, 421(6919), 172-177.
27. Vermot, J.; Forouhar, A.; Liebling, M.; Wu, D.; Plummer, D.; Gharib, M.; et al. (2009). Reversing blood flows act through klf2a to ensure normal valvulogenesis in the developing heart. PLoS Biology, 7(11), e1000246.
28. Bakkers, J. (2011). Zebrafish as a model to study cardiac development and human cardiac disease. Cardiovascular Research, 91(2), 279-288.
29. Glickman, N.; Yelon, D. (2002). Cardiac development in zebrafish: coordination of form and function. Seminars in Cell & Developmental Biology, 13(6), 507-513.
30. Denvir, M.; Tucker, C.; Mullins, J. (2008). Systolic and diastolic ventricular function in zebrafish embryos: influence of norepenephrine, MS-222 and temperature. BMC Biotechnology, 8, 21.
31. Malone, M. H.; Sciaky, N.; Stalheim, L.; Hahn, K. M.; Linney, E.; Johnson, G. L. (2007). Laser-scanning velocimetry: A confocal microscopy method for quantitative measurement of cardiovascular performance in zebrafish embryos and larvae. BMC Biotechnology, 7, 40.
32. Kawakami, K.; Takeda, H.; Kawakami, N.; Kobayashi, M.; Matsuda, N.; Mishina, M. (2004). A transposon-mediated gene trap approach identifies developmentally regulated genes in zebrafish. Developmental Cell, 7(1), 133-144.
33. Seguchi, O.; Takashima, S.; Yamazaki, S.; Asakura, M.; Asano, Y.; Shintani, Y.; et al. (2007). A cardiac myosin light chain kinase regulates sarcomere assembly in the vertebrate heart. The Journal of Clinical Investigation, 117(10), 2812-2824.
34. Richardson, P. (1996). Assessment of myocardial damage in dilated cardiomyopathy. European Heart Journal, 17(4), 489-490.
35. Liu, J.; Bressan, M.; Hassel, D.; Huisken, J.; Staudt, D.; Kikuchi, K.; et al. (2010). A dual role for ErbB2 signaling in cardiac trabeculation. Development, 137(22), 3867-3875.
36. Redwood, C. S.; Moolman-Smook, J. C.; Watkins, H. (1999). Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy. Cardiovascular Research, 44(1), 20-36.
37. Gomes, A.; Barnes, J.; Harada, K.; Potter, J. (2004). Role of troponin T in disease. Molecular and Cellular Biochemistry, 263(1-2), 115-129.
38. Lombardi, R.; Bell, A.; Senthil, V.; Sidhu, J.; Noseda, M.; Roberts, R.; et al. (2008). Differential interactions of thin filament proteins in two cardiac troponin T mouse models of hypertrophic and dilated cardiomyopathies. Cardiovascular Research, 79(1), 109-117.
39. Tardiff, J. C.; Hewett, T. E.; Palmer, B. M.; Olsson, C.; Factor, S. M.; Moore, R. L.; et al. (1999). Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy. The Journal of Clinical Investigation, 104(4), 469-481.